Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDQuarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 9 | -$1.00 | -$0.85 | -$0.88 |
Q2 2024 | 4 | -$0.85 | -$0.72 | -$0.75 |
Q3 2024 | 8 | -$0.83 | -$0.70 | -$0.73 |
Q4 2024 | 10 | -$0.84 | -$0.69 | -$0.78 |
Q1 2025 | 7 | -$0.99 | -$0.61 | -$0.77 |
Q2 2025 | 3 | -$0.84 | -$0.71 | -$0.74 |
Q3 2025 | 6 | -$0.87 | -$0.74 | -$0.77 |
Q4 2025 | 5 | -$0.78 | -$0.66 | -$0.69 |
Q1 2026 | 4 | -$0.71 | -$0.60 | -$0.62 |
Q2 2026 | 3 | -$0.65 | -$0.55 | -$0.58 |
Q3 2026 | 2 | -$0.74 | -$0.63 | -$0.65 |
Q4 2026 | 2 | -$0.57 | -$0.48 | -$0.50 |
Guardant Health, Inc. last posted its earnings results on Wednesday, November 6th, 2024. The company reported $-0.45 earnings per share for the quarter, topping analysts' consensus estimates of $-0.55 by $0.1. The company had revenue of 191.48 M for the quarter and had revenue of 563.95 M for the year. Guardant Health, Inc. has generated $-4 earnings per share over the last year ($-4.28 diluted earnings per share) and currently has a price-to-earnings ratio of -7.58. Guardant Health, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 20th, 2025 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
11/06/2024 | Q3 2024 | -$0.55 | -$0.88 | -0.33 | $170.49 M | $191.48 M |
08/07/2024 | Q2 2024 | -$0.57 | -$0.84 | -0.27 | $162.59 M | $177.24 M |
05/09/2024 | Q1 2024 | -$0.72 | -$0.94 | -0.22 | $168.49 M | |
02/22/2024 | Q4 2023 | -$0.93 | -$1.58 | -0.65 | $155.05 M | |
11/06/2023 | Q3 2023 | -$0.93 | -$0.73 | 0.2 | $137.35 M | $143.03 M |
08/03/2023 | Q2 2023 | -$1.25 | -$0.67 | 0.58 | $129.85 M | $137.15 M |
05/09/2023 | Q1 2023 | -$1.26 | -$1.30 | -0.04 | $128.71 M | |
02/23/2023 | Q4 2022 | -$1.40 | -$1.36 | 0.04 | $126.89 M | |
11/03/2022 | Q3 2022 | -$1.27 | -$1.58 | -0.31 | $117.75 M | $117.40 M |
08/04/2022 | Q2 2022 | -$1.25 | -$2.25 | -1 | $105.08 M | $109.14 M |
05/05/2022 | Q1 2022 | -$1.23 | -$1.21 | 0.02 | $96.10 M | |
02/24/2022 | Q4 2021 | -$0.89 | $108.11 M | |||
11/04/2021 | Q3 2021 | -$0.90 | -$1.06 | -0.16 | $92.01 M | $94.78 M |
08/05/2021 | Q2 2021 | -$0.87 | -$0.96 | -0.09 | $84.52 M | $92.10 M |
05/06/2021 | Q1 2021 | -$0.82 | -$1.09 | -0.27 | $78.67 M | |
02/25/2021 | Q4 2020 | -$0.94 | $78.32 M | |||
11/05/2020 | Q3 2020 | -$0.34 | -$0.78 | -0.44 | $65.93 M | $74.57 M |
08/06/2020 | Q2 2020 | -$0.40 | -$0.57 | -0.17 | $59.18 M | $66.34 M |
05/07/2020 | Q1 2020 | -$0.38 | -$0.29 | 0.09 | $67.51 M | |
03/02/2020 | Q4 2019 | -$0.27 | $62.90 M |
Guardant Health, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 20th, 2025 based off last year's report dates.
In the previous quarter, Guardant Health, Inc. (:GH) reported $-0.45 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.55 by $0.1.
The conference call for Guardant Health, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Guardant Health, Inc.'s latest earnings report can be read online.
Guardant Health, Inc. (:GH) has a recorded annual revenue of $563.95 M.
Guardant Health, Inc. (:GH) has a recorded net income of $563.95 M. Guardant Health, Inc. has generated $-4.28 earnings per share over the last four quarters.
Guardant Health, Inc. (:GH) has a price-to-earnings ratio of -7.58 and price/earnings-to-growth ratio is 2.07.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED